Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7546)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2013 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis. World J Gastroenterol 2013; 19(29): 4808-4817 [PMID: 23922481 DOI: 10.3748/wjg.v19.i29.4808] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v19/i29/4808.htm |
| Number | Citing Articles |
| 1 |
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis. Abdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9
|
| 2 |
Victor Hugo Fonseca de Jesus, Wilson Luiz da Costa Junior, Tomás Mansur Duarte de Miranda Marques, Alessandro Landskron Diniz, Héber Salvador de Castro Ribeiro, André Luis de Godoy, Igor Correia de Farias, Felipe José Fernandez Coimbra. Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single‐center experience from a tertiary hospital in Brazil. Journal of Surgical Oncology 2018; 117(5): 819 doi: 10.1002/jso.25024
|
| 3 |
Yoshiyasu Kato, Suguru Yamada, Mitsuru Tashiro, Fuminori Sonohara, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer. HPB 2019; 21(9): 1211 doi: 10.1016/j.hpb.2019.01.012
|
| 4 |
Andrea Gallamini, Colette Zwarthoed, Anna Borra. Positron Emission Tomography (PET) in Oncology. Cancers 2014; 6(4): 1821 doi: 10.3390/cancers6041821
|
| 5 |
Sanaz Javadi, Vincenzo Wong, Juan J. Ibarra Rovira, Priya Bhosale, Eric Tamm. Pancreatic Cancer: A Multidisciplinary Approach. 2022; : 51 doi: 10.1007/978-3-031-05724-3_5
|
| 6 |
Huajian Gu, Xiaoyan Xin, Yaozhen Pan, Hong Zhang, She Tian, Chengyi Sun. Telomerase Activity as a Marker for Differential Diagnosis of Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis. The International Journal of Biological Markers 2016; 31(2): 126 doi: 10.5301/jbm.5000172
|
| 7 |
Aliya Qayyum, Eric P. Tamm, Ihab R. Kamel, Peter J. Allen, Hina Arif-Tiwari, Victoria Chernyak, Tamas A. Gonda, Joseph R. Grajo, Nicole M. Hindman, Jeanne M. Horowitz, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Pavan K. Srivastava, Tasneem Lalani. ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. Journal of the American College of Radiology 2017; 14(11): S560 doi: 10.1016/j.jacr.2017.08.050
|
| 8 |
Tong Dai, Elizabeta Popa, Manish A. Shah. The Role of 18F-FDG PET Imaging in Upper Gastrointestinal Malignancies. Current Treatment Options in Oncology 2014; 15(3): 351 doi: 10.1007/s11864-014-0301-9
|
| 9 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|
| 10 |
M. Wartski. Bilan initial d’imagerie de l’adénocarcinome pancréatique : données de la littérature sur la place actuelle de la tomographie par émission de positons au 18F-fluorodéoxyglucose (TEP FDG). Médecine Nucléaire 2019; 43(3): 270 doi: 10.1016/j.mednuc.2018.12.018
|
| 11 |
Elena Incerti, Emilia G. Vanoli, Sara Broggi, Calogero Gumina, Paolo Passoni, Najla Slim, Claudio Fiorino, Michele Reni, Paola Mapelli, Mauro Cattaneo, Silvia Zanon, Riccardo Calandrino, Luigi Gianolli, Nadia Di Muzio, Maria Picchio. Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. Nuclear Medicine Communications 2019; 40(10): 1072 doi: 10.1097/MNM.0000000000001065
|
| 12 |
Aline Barhli, Jérôme Cros, Laurent Bartholin, Cindy Neuzillet. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future. Digestive and Liver Disease 2018; 50(10): 979 doi: 10.1016/j.dld.2018.08.009
|
| 13 |
Masatoyo Nakajo, Yoriko Kajiya, Atsushi Tani, Megumi Jinguji, Masayuki Nakajo, Tohru Nihara, Yoshihiko Fukukura, Takashi Yoshiura. A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT. Abdominal Radiology 2017; 42(4): 1210 doi: 10.1007/s00261-016-0987-1
|
| 14 |
Yoshitaka Toyama, Masatoshi Hotta, Fuyuhiko Motoi, Kentaro Takanami, Ryogo Minamimoto, Kei Takase. Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73237-3
|
| 15 |
Daniel Lew, Karl Kwok. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_29-1
|
| 16 |
Lulu Zhang, Santosh Sanagapalli, Alina Stoita. Challenges in diagnosis of pancreatic cancer. World Journal of Gastroenterology 2018; 24(19): 2047-2060 doi: 10.3748/wjg.v24.i19.2047
|
| 17 |
Javier Casillas, Aldo Serafini, Patricia Castillo, Alexander Quiroz, Afonso Ribeiro. Multidisciplinary Teaching Atlas of the Pancreas. 2016; : 91 doi: 10.1007/978-3-662-46745-9_5
|
| 18 |
David R. Fogelman, Gauri Varadhachary. Medical oncology and pancreatic cancer: what the radiologist needs to know. Abdominal Radiology 2018; 43(2): 383 doi: 10.1007/s00261-017-1432-9
|
| 19 |
Kaisa Ahopelto, Kapo Saukkonen, Jaana Hagström, Saila Kauhanen, Hanna Seppänen, Camilla Böckelman, Caj Haglund. TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT. Oncology 2021; 99(3): 177 doi: 10.1159/000510862
|
| 20 |
Wolfgang Mohnike, Gustav Hör, Andreas Hertel. PET/CT-Atlas. 2016; : 507 doi: 10.1007/978-3-662-48842-3_15
|
| 21 |
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & Therapeutics 2015; 155: 80 doi: 10.1016/j.pharmthera.2015.08.006
|
| 22 |
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to know. Clinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
|
| 23 |
Xi Hu, Fan Xia, Jiyoung Lee, Fangyuan Li, Xiaoyang Lu, Xiaozhen Zhuo, Guangjun Nie, Daishun Ling. Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma. Advanced Science 2021; 8(7) doi: 10.1002/advs.202002545
|
| 24 |
Anna La Salvia, Irene Persano, Elena Parlagreco, Alessandro Audisio, Massimiliano Cani, Maria Pia Brizzi. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01764-2
|
| 25 |
Michał Falco, Bartłomiej Masojć, Tadeusz Sulikowski. Radiotherapy in Pancreatic Cancer: To Whom, When, and How?. Cancers 2023; 15(13): 3382 doi: 10.3390/cancers15133382
|
| 26 |
Yong-il Kim, Yong Joong Kim, Jin Chul Paeng, Gi Jeong Cheon, Dong Soo Lee, June-Key Chung, Keon Wook Kang. Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2017; 44(12): 1995 doi: 10.1007/s00259-017-3755-8
|
| 27 |
Norbert Hüser, Volker Aßfalg, Isabel Rauscher, Helmut Friess. The Pancreas. 2018; : 755 doi: 10.1002/9781119188421.ch99
|
| 28 |
Jeho Jeong, Joseph O. Deasy. Modeling the Relationship between Fluorodeoxyglucose Uptake and Tumor Radioresistance as a Function of the Tumor Microenvironment. Computational and Mathematical Methods in Medicine 2014; 2014: 1 doi: 10.1155/2014/847162
|
| 29 |
Gong Zhang, Chengkai Bao, Yanzhe Liu, Zizheng Wang, Lei Du, Yue Zhang, Fei Wang, Baixuan Xu, S. Kevin Zhou, Rong Liu. 18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery. EJNMMI Research 2023; 13(1) doi: 10.1186/s13550-023-00985-4
|
| 30 |
Seong Hun Kim, Seung Ok Lee. Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic Cancer. Gut and Liver 2019; 13(3): 225 doi: 10.5009/gnl19116
|
| 31 |
Mireia Crispin-Ortuzar, Jeho Jeong, Andrew N Fontanella, Joseph O Deasy. A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables. Physics in Medicine and Biology 2017; 62(7): 2658 doi: 10.1088/1361-6560/aa5d42
|
| 32 |
Katharina Seidensaal, Semi Ben Harrabi, Jürgen Debus. Molecular Imaging in Oncology. Recent Results in Cancer Research 2020; 216: 865 doi: 10.1007/978-3-030-42618-7_28
|
| 33 |
Boram Lee, Yoo-Seok Yoon, MeeYoung Kang, Yeshong Park, Eunhye Lee, Yeongsoo Jo, Jun Suh Lee, Hae Won Lee, Jai Young Cho, Ho-Seong Han. Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Surgery. Annals of Surgical Oncology 2023; 30(6): 3444 doi: 10.1245/s10434-022-13043-5
|
| 34 |
Lukas Kessler, Nader Hirmas, Kim M. Pabst, Rainer Hamacher, Justin Ferdinandus, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Michael Nader, Lale Umutlu, Waldemar Uhl, Anke Reinacher-Schick, Celine Lugnier, David Witte, Marco Niedergethmann, Ken Herrmann, Wolfgang P. Fendler, Jens T. Siveke. 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the68Ga-FAPI PET Observational Trial. Journal of Nuclear Medicine 2023; 64(12): 1910 doi: 10.2967/jnumed.122.264827
|
| 35 |
Tonke L. de Jong, Daniëlle Koopman, Corné A.J. van der Worp, Henk Stevens, Floris A. Vuijk, Alexander L. Vahrmeijer, J. Sven D. Mieog, Jan-Willem B. de Groot, Maarten A.C. Meijssen, Vincent B. Nieuwenhuijs, de Geus-Oei Lioe-Fee, Pieter L. Jager, Gijs A. Patijn. Added value of digital FDG-PET/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer. Surgical Oncology 2023; 47: 101909 doi: 10.1016/j.suronc.2023.101909
|
| 36 |
Stephanie R. Rice, Michael Chuong, Antony Koroulakis, Osman M. Siddiqui, Ankur M. Sharma, Charles B. Simone, Jason K. Molitoris, Adeel Kaiser. The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors. PET Clinics 2020; 15(1): 77 doi: 10.1016/j.cpet.2019.08.004
|
| 37 |
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
|
| 38 |
M. Wartski, A. Sauvanet. 18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?. Diagnostic and Interventional Imaging 2019; 100(12): 735 doi: 10.1016/j.diii.2019.07.006
|
| 39 |
Huojun Zhang, Xiaofei Zhu, Zhaochong Zeng, Xianshu Gao. Integrative Pancreatic Intervention Therapy. 2021; : 523 doi: 10.1016/B978-0-12-819402-7.00023-1
|
| 40 |
TaeWoo Kwon, HyeSook Youn, Beomseok Son, Daehoon Kim, Ki Moon Seong, Sungkyun Park, Wanyeon Kim, BuHyun Youn. DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer. Oncotarget 2016; 7(6): 7193 doi: 10.18632/oncotarget.6887
|
| 41 |
M. Wartski, R. Coriat, P.Y. Salaün. Cancers du pancréas. Médecine Nucléaire 2019; 43(1): 61 doi: 10.1016/j.mednuc.2018.12.008
|
| 42 |
Seung Hyup Hyun, Ho Seong Kim, Seong Ho Choi, Dong Wook Choi, Jong Kyun Lee, Kwang Hyuck Lee, Joon Oh Park, Kyung-Han Lee, Byung-Tae Kim, Joon Young Choi. Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(8): 1461 doi: 10.1007/s00259-016-3316-6
|
| 43 |
M.K. Singh. A review of digital PET-CT technology: Comparing performance parameters in SiPM integrated digital PET-CT systems. Radiography 2024; 30(1): 13 doi: 10.1016/j.radi.2023.10.004
|
| 44 |
Terumi Kamisawa, Laura D Wood, Takao Itoi, Kyoichi Takaori. Pancreatic cancer. The Lancet 2016; 388(10039): 73 doi: 10.1016/S0140-6736(16)00141-0
|
| 45 |
Jarrod D. Predina, Andrew D. Newton, Jane Keating, Eduardo M. Barbosa, Olugbenga Okusanya, Leilei Xia, Ashley Dunbar, Courtney Connolly, Michael P. Baldassari, Jack Mizelle, Edward J. Delikatny, John C. Kucharczuk, Charuhas Deshpande, Sumith A. Kularatne, Phillip Low, Jeffrey Drebin, Sunil Singhal. Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules. Annals of Surgery 2017; 266(3): 479 doi: 10.1097/SLA.0000000000002382
|
| 46 |
Kumi Ozaki, Kenichi Harada, Noboru Terayama, Nobuyuki Kosaka, Hirohiko Kimura, Toshifumi Gabata. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Japanese Journal of Radiology 2020; 38(8): 697 doi: 10.1007/s11604-020-00961-1
|
| 47 |
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
|
| 48 |
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
|
| 49 |
Seoung Yoon Rho, Mijin Yun, Chang Moo Kang, Sung Hwan Lee, Ho Kyoung Hwang, Woo Jung Lee. Different biological behaviors in left-sided pancreatic cancer according to Yonsei criteria: Proposal of a modified Yonsei criteria score. Pancreatology 2018; 18(8): 990 doi: 10.1016/j.pan.2018.09.001
|
| 50 |
Friedrich Anger, Anna Döring, Jacob van Dam, Johan Friso Lock, Ingo Klein, Max Bittrich, Christoph-Thomas Germer, Armin Wiegering, Volker Kunzmann, Casper van Eijck, Stefan Löb. Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria. Annals of Surgical Oncology 2021; 28(4): 2325 doi: 10.1245/s10434-020-09100-6
|
| 51 |
Pratyusha Nunna, Sara Sheikhbahaei, Sejin Ahn, Brenda Young, Rathan M. Subramaniam. The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer. Journal of Computer Assisted Tomography 2016; 40(1): 142 doi: 10.1097/RCT.0000000000000323
|
| 52 |
Maxime Ronot, Ashley Kieran Clift, Valérie Vilgrain, Andrea Frilling. Functional imaging in liver tumours. Journal of Hepatology 2016; 65(5): 1017 doi: 10.1016/j.jhep.2016.06.024
|
| 53 |
Dongyong Zhu, Lisha Wang, Hanfei Zhang, Jie Chen, Yanfang Wang, Sama Byanju, Meiyan Liao. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma. Medicine 2017; 96(33): e7813 doi: 10.1097/MD.0000000000007813
|
| 54 |
Monica Greco, Simone Negrini, Chiara Schiavi, Francesca Giusti, Matteo Borro, Chiara Vassallo, Francesco Puppo, Giuseppe Murdaca. An Uncommon Presentation of Pancreatic Carcinoma. The American Journal of Medicine 2019; 132(6): e583 doi: 10.1016/j.amjmed.2019.02.020
|
| 55 |
Naveen M. Kulkarni, Erik V. Soloff, Parag P. Tolat, Guillermo P. Sangster, Jason B. Fleming, Olga R. Brook, Zhen Jane Wang, Elizabeth M. Hecht, Marc Zins, Priya R. Bhosale, Hina Arif-Tiwari, Lorenzo Mannelli, Avinash R. Kambadakone, Eric P. Tamm. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdominal Radiology 2020; 45(3): 716 doi: 10.1007/s00261-019-02289-5
|
| 56 |
Li Wang, Ping Dong, Guohua Shen, Shengzhong Hou, Yi Zhang, Xubao Liu, Bole Tian. 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma. Pancreas 2019; 48(8): 996 doi: 10.1097/MPA.0000000000001375
|
| 57 |
V. M. Petriev, V. K. Tishchenko, R. N. Krasikova. 18F-FDG and Other Labeled Glucose Derivatives for Use in Radionuclide Diagnosis of Oncological Diseases (Review). Pharmaceutical Chemistry Journal 2016; 50(4): 209 doi: 10.1007/s11094-016-1425-y
|
| 58 |
Fathinul Fikri Ahmad Saad, Anna Misyail Abdul Rashid, Mohamad Syafeeq Faeez Md Noh. Incremental Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Computed Tomography-Inconspicuous Pancreatic Lesions. Journal of Pancreatic Cancer 2017; 3(1): 66 doi: 10.1089/pancan.2017.0014
|
| 59 |
Katherine M. Bever, Erkut H. Borazanci, Elizabeth A. Thompson, Jennifer N. Durham, Kimberly Pinero, Gayle S. Jameson, Amber Vrana, Meizheng Liu, Cara Wilt, Annie A. Wu, Wei Fu, Hao Wang, Yafu Yin, Jeffrey P. Leal, Ana De Jesus-Acosta, Lei Zheng, Daniel A. Laheru, Daniel D. Von Hoff, Elizabeth M. Jaffee, Jonathan D. Powell, Dung T. Le. An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma. Oncotarget 2020; 11(21): 1929 doi: 10.18632/oncotarget.27586
|
| 60 |
Yosuke Kasai, Kyoichi Takaori, Etsuro Hatano. The Pancreas. 2023; : 1033 doi: 10.1002/9781119876007.ch133
|
| 61 |
Daniel Lew, Karl Kwok. Hepato-Pancreato-Biliary Malignancies. 2022; : 431 doi: 10.1007/978-3-030-41683-6_29
|
| 62 |
Andreas Odparlik. Kompendium Internistische Onkologie. Springer Reference Medizin 2020; : 1 doi: 10.1007/978-3-662-46764-0_158-1
|
| 63 |
Zaizhu Zhang, Nina Zhou, Xiaoyi Guo, Nan Li, Hua Zhu, Zhi Yang. Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.790462
|
| 64 |
Ricardo P. Martinho, Qingjia Bao, Stefan Markovic, Dina Preise, Keren Sasson, Lilach Agemy, Avigdor Scherz, Lucio Frydman. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13C MRSI, 1H diffusivity and 1H T1 MRI. NMR in Biomedicine 2021; 34(2) doi: 10.1002/nbm.4446
|
| 65 |
Sara Sheikhbahaei, Rick Wray, Brenda Young, Esther Mena, Mehdi Taghipour, Arman Rahmim, Rathan M. Subramaniam. 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma. Nuclear Medicine Communications 2016; 37(3): 231 doi: 10.1097/MNM.0000000000000436
|
| 66 |
Claudio Scafoglio, Bruce A. Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A. Moatamed, Jiaoti Huang, Hermann Koepsell, Jorge R. Barrio, Ernest M. Wright. Functional expression of sodium-glucose transporters in cancer. Proceedings of the National Academy of Sciences 2015; 112(30) doi: 10.1073/pnas.1511698112
|
| 67 |
Nicola Silvestris, Vito Longo, Francesco Cellini, Michele Reni, Alessandro Bittoni, Ivana Cataldo, Stefano Partelli, Massimo Falconi, Aldo Scarpa, Oronzo Brunetti, Vito Lorusso, Daniele Santini, Alessio Morganti, Vincenzo Valentini, Stefano Cascinu. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma. Critical Reviews in Oncology/Hematology 2016; 98: 309 doi: 10.1016/j.critrevonc.2015.11.016
|
| 68 |
Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, Jean-Baptiste Bachet, Lucile Bauguion, Laurianne Colson Durand, Thierry Conroy, Laetitia Dahan, Marine Gilabert, Florence Huguet, Lysiane Marthey, Julie Meilleroux, Louis de Mestier, Bertrand Napoléon, Fabienne Portales, Antonio Sa Cunha, Lilian Schwarz, Julien Taieb, Benoist Chibaudel, Olivier Bouché, Pascal Hammel. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). Digestive and Liver Disease 2018; 50(12): 1257 doi: 10.1016/j.dld.2018.08.008
|
| 69 |
Salvatore Annunziata, Daniele Antonio Pizzuto, Federica Galiandro. Evidence-based Positron Emission Tomography. 2020; : 59 doi: 10.1007/978-3-030-47701-1_7
|
| 70 |
Masato Ogura, Naoto Shikano, Syuichi Nakajima, Junichi Sagara, Naoto Yamaguchi, Kentaro Kusanagi, Yuya Okui, Asuka Mizutani, Masato Kobayashi, Keiichi Kawai. A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: Stimulation of the Warburg effect in AsPC-1 cells. Nuclear Medicine and Biology 2015; 42(5): 475 doi: 10.1016/j.nucmedbio.2014.12.017
|
| 71 |
P. E. Tulin, M. B. Dolgushin, D. I. Nevzorov, P. V. Kochergin, Yu. I. Patyutko. PET/CT IN THE DIAGNOSIS OF PANCREATIC CANCER: LITERATURE REVIEW. Medical Visualization 2018; (1): 57 doi: 10.24835/1607-0763-2018-1-57-67
|
| 72 |
Hong-tao Wei, Guang-yong Chen, Peng Li. Mediastinum metastasis in a post-surgical pancreatic cancer patient successfully confirmed with endoscopic ultrasonography. World Journal of Emergency Medicine 2021; 12(3): 244 doi: 10.5847/wjem.j.1920-8642.2021.03.017
|
| 73 |
G. Layer, E.S. Fuchs, J. Hoffend. Moderne Pankreasdiagnostik bei Tumorverdacht. Der Gastroenterologe 2014; 9(1): 21 doi: 10.1007/s11377-013-0820-0
|
| 74 |
Miikka-Juhani Honka, Eleni Rebelos, Simona Malaspina, Pirjo Nuutila. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer. Metabolites 2022; 12(4): 321 doi: 10.3390/metabo12040321
|
| 75 |
Jin He, David Cosgrove, Joseph M. Herman, Timothy M. Pawlik. Noncolorectal, Nonneuroendocrine Liver Metastases. 2015; : 95 doi: 10.1007/978-3-319-09293-5_8
|
| 76 |
Hyung Rae Kim, Minjung Seo, Yang Won Nah, Hyung Woo Park, Seol Hoon Park. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer. Nuclear Medicine Communications 2018; 39(7): 691 doi: 10.1097/MNM.0000000000000855
|
| 77 |
Fanxiao Liu, Qingyu Zhang, Dezhi Zhu, Fengxia Liu, Zhenfeng Li, Jianmin Li, Bomin Wang, Dongsheng Zhou, Jinlei Dong. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma. Medicine 2015; 94(36): e1462 doi: 10.1097/MD.0000000000001462
|
| 78 |
Tamara M H Gall, Harpreet Wasan, Long R Jiao. Pancreatic cancer: current understanding of molecular and genetic aetiologies. Postgraduate Medical Journal 2015; 91(1080): 594 doi: 10.1136/postgradmedj-2014-133161
|
| 79 |
Lei Jiang, Qiying Tang, Cedric Panje, Hongting Nie, Guochao Zhao, Hongcheng Shi. Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT. Oncology Letters 2018; doi: 10.3892/ol.2018.8859
|
| 80 |
Asha Kandathil, Rathan M. Subramaniam. Imaging Diagnostics in Pancreatic Cancer. Clinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-69940-6_5
|
| 81 |
Jin-Ping Lai, Yong Yue, Wei Zhang, Yihua Zhou, David Frishberg, Laith H. Jamil, James M. Mirocha, Maha Guindi, Bonnie Balzer, Shikha Bose, Dengfeng Cao, Simon Lo, Xuemo Fan, Joanne K. Rutgers. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma. Pancreatology 2017; 17(4): 617 doi: 10.1016/j.pan.2017.04.008
|
| 82 |
Wataru Izumo, Ryota Higuchi, Toru Furukawa, Takehisa Yazawa, Shuichiro Uemura, Masahiro Shiihara, Masakazu Yamamoto. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma. Surgery 2020; 168(6): 994 doi: 10.1016/j.surg.2020.01.014
|
| 83 |
Yasuo Otsuka, Ken Kamata, Masatoshi Kudo. Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Puncture for the Patients with Pancreatic Masses. Diagnostics 2023; 13(6): 1039 doi: 10.3390/diagnostics13061039
|
| 84 |
Paula Ghaneh, Robert Hanson, Andrew Titman, Gill Lancaster, Catrin Plumpton, Huw Lloyd-Williams, Seow Tien Yeo, Rhiannon Tudor Edwards, Colin Johnson, Mohammed Abu Hilal, Antony P Higginson, Tom Armstrong, Andrew Smith, Andrew Scarsbrook, Colin McKay, Ross Carter, Robert P Sutcliffe, Simon Bramhall, Hemant M Kocher, David Cunningham, Stephen P Pereira, Brian Davidson, David Chang, Saboor Khan, Ian Zealley, Debashis Sarker, Bilal Al Sarireh, Richard Charnley, Dileep Lobo, Marianne Nicolson, Christopher Halloran, Michael Raraty, Robert Sutton, Sobhan Vinjamuri, Jonathan Evans, Fiona Campbell, Jon Deeks, Bal Sanghera, Wai-Lup Wong, John P Neoptolemos. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technology Assessment 2018; 22(7): 1 doi: 10.3310/hta22070
|
| 85 |
Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jong-Chan Lee, Young Soo Park, Nayoung Kim. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10<sup>th</sup> codes: A retrospective large-cohort study. World Journal of Gastroenterology 2019; 25(37): 5619-5629 doi: 10.3748/wjg.v25.i37.5619
|
| 86 |
Xinjin Gu, Ruiquan Zhou, Chenggang Li, Rong Liu, Zhiming Zhao, Yuanxing Gao, Yong Xu. Preoperative maximum standardized uptake value and carbohydrate antigen 19–9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5691-4
|
| 87 |
Venkata Subramanian Krishnaraju, Rajender Kumar, Bhagwant Rai Mittal, Vishal Sharma, Harjeet Singh, Ritambhra Nada, Amanjit Bal, Manish Rohilla, Harmandeep Singh, Surinder S. Rana. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue. European Radiology 2021; 31(4): 2199 doi: 10.1007/s00330-020-07318-2
|
| 88 |
Krzysztof Kilian, Bartłomiej Chabecki, Justyna Kiec, Agnieszka Kunka, Barbara Panas, Maciej Wójcik, Anna Pękal. Synthesis, quality control and determination of metallic impurities in 18F-fludeoxyglucose production process. Reports of Practical Oncology & Radiotherapy 2014; 19: S22 doi: 10.1016/j.rpor.2014.03.001
|
| 89 |
Wataru Izumo, Ryota Higuchi, Toru Furukawa, Takehisa Yazawa, Shuichirou Uemura, Masahiro Shiihara, Masakazu Yamamoto. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma. Scandinavian Journal of Gastroenterology 2019; 54(6): 780 doi: 10.1080/00365521.2019.1624816
|
| 90 |
Jeong Won Lee, Joo Hyun O, Miyoung Choi, Joon Young Choi. Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis. Diagnostics 2020; 10(11): 952 doi: 10.3390/diagnostics10110952
|
| 91 |
Norbert Hüser, Volker Aßfalg, Isabel Rauscher, Helmut Friess. The Pancreas. 2023; : 1021 doi: 10.1002/9781119876007.ch131
|
| 92 |
Juliano J. Cerci, Mateos Bogoni, Dominique Delbeke. Oncological PET/CT with Histological Confirmation. 2016; : 77 doi: 10.1007/978-3-319-27880-3_7
|
| 93 |
Ja Kyung Yoon, Mi-Suk Park, Seung-Seob Kim, Kyunghwa Han, Hee Seung Lee, Seungmin Bang, Ho Kyoung Hwang, Sang Hyun Hwang, Mijin Yun, Myeong-Jin Kim. Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-22126-y
|
| 94 |
Bhasker R. Koppula, Gabriel C. Fine, Ahmed Ebada Salem, Matthew F. Covington, Richard H. Wiggins, John M. Hoffman, Kathryn A. Morton. PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies. Cancers 2022; 14(11): 2668 doi: 10.3390/cancers14112668
|
| 95 |
Yahui Zhu, Jing Zhou, Lijing Zhu, Wenjing Hu, Baorui Liu, Li Xie. Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer. Human Vaccines & Immunotherapeutics 2022; 18(5) doi: 10.1080/21645515.2022.2060019
|